Live
Home·Deals·medical·Servier acquires Day One Biopharma
Servier acquires Day One Biopharma (2026)
SEO URLwww.firestrike.ai/deals/day-one-biopharma-servier-acquisition-2026-9
acquisitionAnnounced · Mar 6, 2026medicalSource · CredibleArticle · Factual
Day One Biopharma
Servier
Day One Biopharma · Servier

Servier acquires Day One Biopharma

David Najork
David Najork · Founding Software Engineer
Published · Updated · 1 min read
ShareXLinkedInEmail
Deal value
$2.5B
Target
Day One Biopharma
Day One Biopharma
NASDAQ: DAWN · Brisbane, California
Acquirer
Servier
Servier
Full Acquisition
Status
Pending

Servier agreed to acquire Day One Biopharma. Reported deal value: $2.5B. Status: Pending. Sector: medical. Target headquarters context: Brisbane, California, United States.

This page summarizes publicly available information about the transaction as of 2026-03-06. Figures and status may change as filings and press coverage update.

Day One Biopharmaceuticals to be acquired by Servier in $2.5 Billion Deal

Deal timeline

Announced
Mar 6, 2026 · marketscreener.com
Additional milestones (proxy, vote, close) appear as filings and press updates are indexed.
Sector context

This transaction is classified in medical with a reported deal value of $2.5B. Figures and status may change as sources update.

Sources: marketscreener.com · Primary article · FireStrike proprietary index